MPMyong‐Suk Park

Myong‐Suk Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Myong‐Suk Park has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Woo Kyun Bae

    Division of Hemato‐Oncology, Department of Internal Medicine Chonnam National University Medical School and Hwasun Hospital Hwasun Republic of Korea

    3 shared publications
  • Chaeun Oh

    Department of Biological Sciences Sookmyung Women's University Seoul Republic of Korea

    2 shared publications
  • Hyeri Jeon

    Department of Chemistry & Nanoscience Ewha Womans University Seoul Republic of Korea

    2 shared publications
  • Hyungbin Park

    Department of Chemistry & Nanoscience Ewha Womans University Seoul Republic of Korea

    2 shared publications
  • Jiseon Ha

    Department of Biological Sciences Sookmyung Women's University Seoul Republic of Korea

    2 shared publications
  • Junho Lee

    Division of Medical Oncology‐Hematology Kyung Hee University Hospital, Kyung Hee University College of Medicine Seoul Republic of Korea

    2 shared publications

Latest Publications

  • Metal‐Center‐Controlled Fenton‐Like Reactivity of Biomimetic First‐Row Transition Metal Complexes in Aqueous Anticancer Catalysis

    by Hyungbin Park, Sungju Jung, Junho Lee, Myong‐Suk Park, Jiseon Ha, Hyeri Jeon, Chaeun Oh, Woo Kyun Bae, Kyung Hyun Yoo, Seungwoo Hong

    Catalytic oxidative cancer therapy exploits elevated hydrogen peroxide levels within tumor microenvironments to induce selective oxidative damage in malignant cells. However, many ROS‐generating therapeutic systems rely on heavy metals or structurally complex inorganic architectures, limiting their biological compatibility and catalytic selectivity. Inspired by nonheme iron‐mediated redox catalysis, we report a series of water‐soluble biomimetic first‐row transition metal complexes supported by a picolylamine‐derived nonheme ligand scaffold bearing a pendant hydroxyl group. Systematic variation of the metal center (Mn, Fe, Co, Ni, Cu, and Zn) generated divergent electrochemical behavior and distinct peroxide‐activation reactivity, yet only the iron complex, [Fe(N 2 Py 3 OH)] 2+ ( 1‐Fe ), promoted hydroxyl radical formation via Fenton‐like hydrogen peroxide activation in water. Spectroscopic, electrochemical, and crystallographic analyses revealed a biomimetic coordination environment that stabilizes a quasi‐reversible Fe(II)/Fe(III) redox couple suited to catalytic peroxide activation. In gastric cancer cells, 1‐Fe induced intracellular oxidative stress, mitochondrial depolarization, lipid peroxidation, and concomitant apoptosis and ferroptosis, while exhibiting negligible toxicity toward normal fibroblasts. In combination with paclitaxel, 1‐Fe produced synergistic antiproliferative activity in vitro and suppressed peritoneal tumor dissemination in vivo without overt systemic toxicity. Collectively, these results establish biomimetic iron complexes as molecular platforms for Fenton‐like oxidative catalysis in redox‐based cancer therapy.

  • Metal‐Center‐Controlled Fenton‐Like Reactivity of Biomimetic First‐Row Transition Metal Complexes in Aqueous Anticancer Catalysis

    by Hyungbin Park, Sungju Jung, Junho Lee, Myong‐Suk Park, Jiseon Ha, Hyeri Jeon, Chaeun Oh, Woo Kyun Bae, Kyung Hyun Yoo, Seungwoo Hong

    Catalytic oxidative cancer therapy exploits elevated hydrogen peroxide levels within tumor microenvironments to induce selective oxidative damage in malignant cells. However, many ROS‐generating therapeutic systems rely on heavy metals or structurally complex inorganic architectures, limiting their biological compatibility and catalytic selectivity. Inspired by nonheme iron‐mediated redox catalysis, we report a series of water‐soluble biomimetic first‐row transition metal complexes supported by a picolylamine‐derived nonheme ligand scaffold bearing a pendant hydroxyl group. Systematic variation of the metal center (Mn, Fe, Co, Ni, Cu, and Zn) generated divergent electrochemical behavior and distinct peroxide‐activation reactivity, yet only the iron complex, [Fe(N 2 Py 3 OH)] 2+ ( 1‐Fe ), promoted hydroxyl radical formation via Fenton‐like hydrogen peroxide activation in water. Spectroscopic, electrochemical, and crystallographic analyses revealed a biomimetic coordination environment that stabilizes a quasi‐reversible Fe(II)/Fe(III) redox couple suited to catalytic peroxide activation. In gastric cancer cells, 1‐Fe induced intracellular oxidative stress, mitochondrial depolarization, lipid peroxidation, and concomitant apoptosis and ferroptosis, while exhibiting negligible toxicity toward normal fibroblasts. In combination with paclitaxel, 1‐Fe produced synergistic antiproliferative activity in vitro and suppressed peritoneal tumor dissemination in vivo without overt systemic toxicity. Collectively, these results establish biomimetic iron complexes as molecular platforms for Fenton‐like oxidative catalysis in redox‐based cancer therapy.

  • Open Access

    Role of Immunosuppressive Microenvironment in Acquiring Immunotolerance Post-Photothermal Therapy

    by Kondareddy Cherukula, Myung Suk Park, Adonijah Graham Sontyana, Ansuja Pulickal Mathew, Veena Vijayan, Woo Kyun Bae, In-Kyu Park

    Cherukula K, et al. J Korean Med Sci. 2019 Oct;34(44):e272. https://doi.org/10.3346/jkms.2019.34.e272